Exact Mass: 445.2038
Exact Mass Matches: 445.2038
Found 203 metabolites which its exact mass value is equals to given mass value 445.2038
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
P-Hydroxyhippuryl-his-leu-OH
Ala Cys Pro Arg
Ala Cys Arg Pro
Ala Met Pro Gln
Ala Met Gln Pro
Ala Pro Cys Arg
Ala Pro Met Gln
Ala Pro Gln Met
Ala Pro Arg Cys
Ala Gln Met Pro
Ala Gln Pro Met
Ala Arg Cys Pro
Ala Arg Pro Cys
Cys Ala Pro Arg
Cys Ala Arg Pro
Cys Ile Asn Pro
Cys Ile Pro Asn
Cys Leu Asn Pro
Cys Leu Pro Asn
Cys Asn Ile Pro
Cys Asn Leu Pro
Cys Asn Pro Ile
Cys Asn Pro Leu
Cys Pro Ala Arg
Cys Pro Ile Asn
Cys Pro Leu Asn
Cys Pro Asn Ile
Cys Pro Asn Leu
Cys Pro Gln Val
Cys Pro Arg Ala
Cys Pro Val Gln
Cys Gln Pro Val
Cys Gln Val Pro
Cys Arg Ala Pro
Cys Arg Pro Ala
Cys Val Pro Gln
Cys Val Gln Pro
Gly Pro Ser Trp
Gly Pro Trp Ser
Gly Ser Pro Trp
Gly Ser Trp Pro
Gly Trp Pro Ser
Gly Trp Ser Pro
Ile Cys Asn Pro
Ile Cys Pro Asn
Ile Asn Cys Pro
Ile Asn Pro Cys
Ile Pro Cys Asn
Ile Pro Asn Cys
Leu Cys Asn Pro
Leu Cys Pro Asn
Leu Asn Cys Pro
Leu Asn Pro Cys
Leu Pro Cys Asn
Leu Pro Asn Cys
Met Ala Pro Gln
Met Ala Gln Pro
Met Pro Ala Gln
Met Pro Gln Ala
Met Gln Ala Pro
Met Gln Pro Ala
Asn Cys Ile Pro
Asn Cys Leu Pro
Asn Cys Pro Ile
Asn Cys Pro Leu
Asn Ile Cys Pro
Asn Ile Pro Cys
Asn Leu Cys Pro
Asn Leu Pro Cys
Asn Pro Cys Ile
Asn Pro Cys Leu
Asn Pro Ile Cys
Asn Pro Leu Cys
Pro Ala Cys Arg
Pro Ala Met Gln
Pro Ala Gln Met
Pro Ala Arg Cys
Pro Cys Ala Arg
Pro Cys Ile Asn
Pro Cys Leu Asn
Pro Cys Asn Ile
Pro Cys Asn Leu
Pro Cys Gln Val
Pro Cys Arg Ala
Pro Cys Val Gln
Pro Gly Ser Trp
Pro Gly Trp Ser
Pro Ile Cys Asn
Pro Ile Asn Cys
Pro Leu Cys Asn
Pro Leu Asn Cys
Pro Met Ala Gln
Pro Met Gln Ala
Pro Asn Cys Ile
Pro Asn Cys Leu
Pro Asn Ile Cys
Pro Asn Leu Cys
Pro Gln Ala Met
Pro Gln Cys Val
Pro Gln Met Ala
Pro Gln Val Cys
Pro Arg Ala Cys
Pro Arg Cys Ala
Pro Ser Gly Trp
Pro Ser Trp Gly
Pro Val Cys Gln
Pro Val Gln Cys
Pro Trp Gly Ser
Pro Trp Ser Gly
Gln Ala Met Pro
Gln Ala Pro Met
Gln Cys Pro Val
Gln Cys Val Pro
Gln Met Ala Pro
Gln Met Pro Ala
Gln Pro Ala Met
Gln Pro Cys Val
Gln Pro Met Ala
Gln Pro Val Cys
Gln Val Cys Pro
Gln Val Pro Cys
Arg Ala Cys Pro
Arg Ala Pro Cys
Arg Cys Ala Pro
Arg Cys Pro Ala
Arg Pro Ala Cys
Arg Pro Cys Ala
Ser Gly Pro Trp
Ser Gly Trp Pro
Ser Pro Gly Trp
Ser Pro Trp Gly
Ser Trp Gly Pro
Ser Trp Pro Gly
Val Cys Pro Gln
Val Cys Gln Pro
Val Pro Cys Gln
Val Pro Gln Cys
Val Gln Cys Pro
Val Gln Pro Cys
Trp Gly Pro Ser
Trp Gly Ser Pro
Trp Pro Gly Ser
Trp Pro Ser Gly
Trp Ser Gly Pro
Trp Ser Pro Gly
3,4-Dimethoxy-N-[3-(1,2,3,4-tetrahydro-7-isoquinolinylcarbamoyl)b enzyl]benzamide
magnesium 1,4-bis(2-ethylhexyl) 2-sulphonatosuccinate
N4-BENZOYL-5-O-TERT-BUTYLDIMETHYLSILYL-2-DEOXYCYTIDINE
5-O-TBDMS-N4-Benzoyl-2-deoxycytidine is a modified nucleoside. 5-O-TBDMS-N4-Benzoyl-2-deoxycytidine can be used in the synthesis of deoxyribonucleic acid or nucleic acid.
Selonsertib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
(2S,5S)-1-(4-(tert-butyl)phenyl)-2,5-bis(4-nitrophenyl)pyrrolidine
(2E)-9-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}non-2-enoic acid
(2E,8R)-8-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}non-2-enoic acid
4-(2-Aminoethoxy)-N-(3-Chloro-2-Ethoxy-5-Piperidin-1-Ylphenyl)-3,5-Dimethylbenzamide
1-((1R)-1-(Hydroxymethyl)-3-{6-[(3-phenylpropanoyl)amino]-1H-indol-1-YL}propyl)-1H-imidazole-4-carboxamide
2-Cyano-2-[3-[4-(phenylmethyl)-1-piperazinyl]-2-quinoxalinyl]acetic acid 2-methoxyethyl ester
2-(2,4-Dimethoxyphenyl)-5-methyl-4-[[4-(4-quinazolinyl)-1-piperazinyl]methyl]oxazole
N-[(E)-(4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ylidene)amino]benzamide
8-methoxy-3-[(E)-[4-methoxy-3-(1-pyrrolidinylmethyl)phenyl]methylideneamino]-2-methyl-5H-pyrimido[5,4-b]indol-4-one
(1R,9S,10S,11S)-10-(hydroxymethyl)-5-(4-methoxyphenyl)-12-methyl-6-oxo-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(3R)-3-(2-hydroxyethyl)-N,N-dimethyl-2-(1-oxopropyl)-4-[3-(5-pyrimidinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(1S,9R,10R,11R)-10-(hydroxymethyl)-5-(4-methoxyphenyl)-12-methyl-6-oxo-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
[(2S,3S)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]-pyridin-2-ylmethanone
[(2R,3R)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]-pyridin-2-ylmethanone
(1S,19S)-9,9,16,16-tetramethyl-14-oxido-8-oxa-23,25-diaza-14-azoniaheptacyclo[17.5.2.01,17.03,15.04,13.07,12.019,23]hexacosa-2,4(13),5,7(12),10,14-hexaene-24,26-dione
(1S,3S,12Z)-1-hydroxy-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.018,23]hexacosa-8,12,15,17(26),18(23),19,24-heptaene-4,10-dione
PQR620
PQR620 is an orally bioavailable and selective brain penetrant inhibitor of mTORC1/2[1]. PQR620 is an orally bioavailable and selective brain penetrant inhibitor of mTORC1/2[1].